Good for health, great for the economy: collaborations between pharmaceutical companies and the healthcare system in Israel
07.02.23|Sponsored Content
More countries are discovering the economic and medical benefits that come with collaboration between pharmaceutical companies and healthcare systems. This collaborative model has already been successfully implemented by the Swiss company Novartis and the National Healthcare System (NHS) in England. The benefits include improved treatment of sclerotic cardiovascular diseases and higher economic efficiency on a national level. Is Israel next in line for a healthcare revolution? 
